Publications 2014
Sánchez-Niño, M. D.; Poveda, J.; Sanz, A. B.; Carrasco, S.; Ruiz-Ortega, M.; Selgas, R.; Egido, J.; Ortiz, A. 3,4-DGE is cytotoxic and decreases HSP27/HSPB1 in podocytes. ARCHIVES OF TOXICOLOGY. 2014; 88(3): 597-608. Artículo. 5.98 D1
Sánchez-Niño, M. D.; Ortiz, A. Differential effects of oral and intravenous l-carnitine on serum lipids: is the microbiota the answer? CLINICAL KIDNEY JOURNAL. 2014; 7(5): 437-441. Artículo. No Indexado No Indexado
Fernández-Romero, N.; Quilés, I.; Jiménez, C.; Oliva, M. O. L.; Rivas, B.; Mingorance, J.; Romero-Gómez, M. P. Use of multiplex PCR in diagnosis of bloodstream infections in kidney patients. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. 2014; 80(2): 93-96. Artículo. 2.457 Q3
Nastou, D.; Fernández-Fernández, B.; Elewa, U.; González-Espinoza, L.; González-Parra, E.; Sánchez-Niño, M. D.; Ortiz, A. Next-generation phosphate binders: focus on iron-based binders. DRUGS. 2014; 74(8): 863-877. Artículo. 4,343 Q1
López-Oliva, M. O.; Rivas, B.; Pérez-Fernández, E.; Ossorio, M.; Ros, S.; Chica, C.; Aguilar, A.; Bajo, M. A.; Escuín, F.; Hidalgo, L.; Selgas, R.; Jiménez, C. Pretransplant peritoneal dialysis relative to hemodialysis improves long-term survival of kidney transplant patients: a singlecenter observational study. INTERNATIONAL UROLOGY AND NEPHROLOGY. 2014; 46(4): 825-832. Artículo. 1,519 Q3
Barril, G.; Quiroga, J. A.; Arenas, M. D.; Espinosa, M.; García-Fernández, N.; Cigarrán, S.; Herrero, J. A.; Caro, P.; García-Agudo, R.; Amezquita, Y.; Blanco, A.; Martínez-Rubio, P.; Alcázar, J. M.; González-Parra, E.; Martín-Gómez, A.; Castillo, I.; Bartolomé, J.; Carreno, V. Impact of isolated hepatitis C Virus (HCV) Core-specific antibody detection and viral RNA amplification among HCV-seronegative dialysis patients at risk for infection. JOURNAL OF CLINICAL MICROBIOLOGY. 2014; 52(8): 3053-3056. Artículo. 3,993 Q1
García-Llana, H.; Remor, E.; del Peso, G.; Celadilla, O.; Selgas, R. Motivational interviewing promotes adherence and improves wellbeing in pre-dialysis patients with advanced chronic kidney disease. JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS. 2014; 21(1): 103-115. Artículo. No Indexado No Indexado
Castillo, I.; Martínez-Ara, J.; Olea, T.; Bartolome, J.; Madero, R.; Hernández, E.; Bernis, C.; Aguilar, A.; Quiroga, J. A.; Carreno, V.; Selgas, R. High prevalence of occult hepatitis C virus infection in patients with primary and secondary glomerular nephropathies. KIDNEY INTERNATIONAL. 2014; 86(3): 619-624. Artículo. 8,563 D1
Rodrígues-Díez, R.; Aroeira, L. S.; Orejudo, M.; Bajo, M. A.; Heffernan, J. J.; Rodrígues-Díez, R. R.; Rayego-Mateos, S.; Ortiz, A.; González-Mateo, G.; López-Cabrera, M.; Selgas, R.; Egido, J.; Ruiz-Ortega, M. IL-17A is a novel player in dialysis-induced peritoneal damage. KIDNEY INTERNATIONAL. 2014; 86(2): 303-315. Artículo. 8,563 D1
García-Llana, H.; Remor, E.; del Peso, G.; Selgas, R. The role of depression, Anxiety, stress and adherence to treatment in dialysis patients’ health-related quality of life: a systematic review of the literature. NEFROLOGÍA. 2014; 34(5): 637-657. Artículo. 1,223 Q3
Sánchez-Villanueva, R. J.; González, E.; Quirce, S.; Díaz, R.; Álvarez, L.; Menéndez, D.; Rodríguez-Gayo, L.; Bajo, M. A.; Selgas, R. Hypersensitivity reactions to synthetic haemodialysis membranes. NEFROLOGÍA. 2014; 34(4): 520-525. Artículo. 1,223 Q3
Tapia-Canelas, C.; Zometa, R.; López-Oliva, M. O.; Jiménez, C.; Rivas, B.; Escuín, F.; Yébenes, L.; Selgas, R. Complications associated with renal graft biopsy in transplant patients. NEFROLOGÍA. 2014; 34(1): 115-119. Artículo. 1,223 Q3
Poveda, J.; Sánchez-Niño, M. D.; Glorieux, G.; Sanz, A. B.; Egido, J.; Vanholder, R.; Ortiz, A. p-Cresyl sulphate has pro-inflammatory and cytotoxic actions on human proximal tubular epithelial cells. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2014; 29(1): 56-64. Artículo. 3,577 Q1
de Sousa-Amorim, E.; del Peso, G.; Bajo, M. A.; Álvarez, L.; Ossorio, M.; Gil, F.; Bellón, T.; Selgas, R. Can EPS development be avoided with early interventions? the potential role of tamoxifen-a single-center study. PERITONEAL DIALYSIS INTERNATIONAL. 2014; 34(6): 582-593. Artículo. 1,527 Q3
de Sousa, E.; del Peso, G.; Álvarez, L.; Ros, S.; Mateus, A.; Aguilar, A.; Selgas, R.; Bajo, M. A. Peritoneal resting with heparinized lavage reverses peritoneal type i membrane failure. A comparative study of the resting effects on normal membranes. PERITONEAL DIALYSIS INTERNATIONAL. 214; 34(7): 698-705. Artículo. 1,527 Q3
González-Mateo, G. T.; Fernández-Millara, V.; Bellón, T.; Liappas, G.; Ruiz-Ortega, M.; López-Cabrera, M.; Selgas, R.; Aroeira, L. S. Paricalcitol reduces peritoneal fibrosis in mice through the activation of regulatory t cells and reduction in IL-17 production. PLOS ONE. 2014; 9(10): e108477. Artículo. 3,234 Q1
Sanz, A. B.; Aroeira, L. S.; Bellón, T.; del Peso, G.; Jiménez-Heffernan, J.; Santamaría, B.; Sánchez-Niño, M. D.; Blanco-Colio, L. M.; López-Cabrera, M.; Ruiz-Ortega, M.; Egido, J.; Selgas, R.; Ortiz, A. TWEAK Promotes Peritoneal Inflammation. PLOS ONE. 2014; 9(3): e90399. Artículo. 3,234 Q1
López-Oliva, M. O.; Martínez, V.; Buitrago, A.; Jiménez, C.; Rivas, B.; Escuín, F.; Santana, M. J.; Selgas, R.; Bellón, T. Effects of simultaneous iliac artery angioplasty on graft and patient survival after living-donor kidney transplantation. TRANSPLANTATION. 2014; 97(8): 839-845. Artículo. 3,828 D1
Izquierdo, M. C.; Martín-Cleary, C.; Fernández-Fernández, B.; Elewa, U.; Sánchez-Niño, M. D.; Carrero, J. J.; Ortiz, A. CXCL16 in kidney and cardiovascular injury. CYTOKINE & GROWTH FACTOR REVIEWS. 2014; 25(3): 317-325. Revisión. 5,357 Q1
Tabara, L. C.; Poveda, J.; Martín-Cleary, C.; Selgas, R.; Ortiz, A.; Sánchez-Niño, M. D. Mitochondria-targeted therapies for acute kidney injury. EXPERT REVIEWS IN MOLECULAR MEDICINE. 2014; 16: e13. Revisión. 5,152 Q1
Sanz, A. B.; Sánchez-Niño, M. D.; Izquierdo, M. C.; González-Espinoza, L.; Ucero, A. C.; Poveda, J.; Ruiz-Andrés, O.; Ruiz-Ortega, M.; Selgas, R.; Egido, J.; Ortiz, A. Macrophages and recently identified forms of cell death. INTERNATIONAL REVIEWS OF IMMUNOLOGY. 2014; 33(1): 9-22. Revisión. 4,103 Q2
Ucero, A. C.; Benito-Martín, A.; Izquierdo, M. C.; Sánchez-Niño, M. D.; Sanz, A. B.; Ramos, A. M.; Berzal, S.; Ruiz-Ortega, M.; Egido, J.; Ortiz, A. Unilateral ureteral obstruction: beyond obstruction. INTERNATIONAL UROLOGY AND NEPHROLOGY. 2014; 46(4): 765-776. Revisión. 1,519 Q3
Montáñez-Barragán, A.; Gómez-Barrera, I.; Sánchez-Niño, M. D.; Ucero, A. C.; González-Espinoza, L.; Ortiz, A. Osteoprotegerin and kidney disease. JOURNAL OF NEPHROLOGY. 2014; 27(6): 607-617. Revisión. 1,454 Q3
Díaz-García, J. D.; Gallegos-Villalobos, A.; González-Espinoza, L.; Sánchez-Niño, M. D.; Villarrubia, J.; Ortiz, A. Deferasirox nephrotoxicitythe knowns and unknowns. NATURE REVIEWS NEPHROLOGY. 2014; 10(10): 574-586. Revisión. 8,542 D1
Sanz, A. B.; Izquierdo, M. C.; Sánchez-Niño, M. D.; Ucero, A. C.; Egido, J.; Ruiz-Ortega, M.; Ramos, A. M.; Putterman, C.; Ortiz, A. TWEAK and the progression of renal disease: clinical translation. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2014; 29(1): 154-162. Revisión. 3,577 Q1
Publications 2009 - 2013
2013 López-Hellín, J.; Cantarell, C.; Jimeno, L.; Sánchez-Fructuoso, A.; Puig-Gay, N.; Guirado, L.; Vilarino, N.; González-Roncero, F. M.; Mazuecos, A.; Lauzurica, R.; Burgos, D.; Plumed, J. S.; Jacobs-Cacha, C.; Jiménez, C.; Fernández, A.; FernándezÁlvarez, P.; Torregrosa, V.; Nieto, J. L.; Meseguer, A.; Alonso, A. A form of apolipoprotein A-I is found specifically in relapses of focal segmental glomerulosclerosis following transplantation. AMERICAN JOURNAL OF TRANSPLANTATION. 2013; 13(2): 493-500. Artículo. 6,19 D1
2013 Sánchez-Niño, M. D.; Poveda, J.; Sanz, A. B.; Mezzano, S.; Carrasco, S.; Fernández-Fernández, B.; Burkly, L. C.; Nair, V.;
Kretzler, M.; Hodgin, J. B.; Ruiz-Ortega, M.; Selgas, R.; Egido, J.; Ortiz, A. Fn14 in podocytes and proteinuric kidney disease. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2013; 1832(12): 2232-2243. Artículo.
5.089 Q1
2013 Husi, H.; Sánchez-Niño, M. D.; Delles, C.; Mullen, W.; Vlahou,
A.; Ortiz, A.; Mischak, H. A combinatorial approach of proteomics
and systems biology in unravelling the mechanisms of acute kidney injury (AKI): involvement of NMDA receptor GRIN1 in murine AKI. BMC SYSTEMS BIOLOGY. 2013: 7: 110. Article.
2013 Ramos, R.; Fontán, M. P.; Sánchez, E.; Bajo, A.; Barbosa, F.;
Borrás, M.; González, T. Effectiveness of treatment with oral paricalcitol in patients on peritoneal dialysis: a Spanish multicenter
study. CLINICAL NEPHROLOGY. 2013; 79(5): 394-401. Artículo.
1.232 Q3
2013 Tavira, B.; Gómez, J.; Ortega, F.; Tranche, S.; Díaz-Corte, C.;
Álvarez, F.; Ortiz, A.; Santos, F.; Sánchez-Niño, M. D.; Coto, E.
A CLCNKA polymorphism (rs10927887; p.Arg83Gly) previously
linked to heart failure is associated with the estimated glomerular
filtration rate in the RENASTUR cohort. GENE. 2013; 527(2): 670-672.Artículo.
2.082 Q3
2013 Loureiro, J.; González-Mateo, G.; Jiménez-Heffernan, J.; Selgas, R.; López-Cabrera, M.; Aguilera Peralta, A. Are the mesothelial-to-mesenchymal transition, sclerotic peritonitis syndromes, and encapsulating peritoneal sclerosis part of the same process? INTERNATIONAL JOURNAL OF NEPHROLOGY. 2013; 2013: 263285. Artículo. Not Indexed Not Indexed
2013 Peces, R.; Peces, C.; de Sousa, E.; Vega, C.; Selgas, R.; Nevado,
J. A novel and de novo deletion in the OCRL1 gene associated with a severe form of Lowe syndrome. INTERNATIONAL UROLOGY AND NEPHROLOGY. 2013; 45(6): 1767-1771. Artículo.
1.293 Q3
2013 Vega-Cabrera, C.; del Peso, G.; Bajo, A.; Picazo, M. L.; Rivas-
Becerra, B.; Benítez, A. L.; Ara, J. M.; Olea, T.; Selgas, R. Goodpasture’s syndrome associated with thrombotic hrombocytopenic purpura secondary to an ADAMTS-13 deficit.
INTERNATIONAL UROLOGY AND NEPHROLOGY. 2013; 45(6): 1785-1789. Artículo.
1.293 Q3
2013 Iglesias, P.; Olea, T.; Vega-Cabrera, C.; Heras, M.; Bajo, M. A.;
del Peso, G.; Arias, M. J.; Selgas, R.; Díez, J. J. Thyroid function
tests in acute kidney injury. JOURNAL OF NEPHROLOGY. 2013; 26(1): 164-172. Artículo.
1.996 Q2
2013 Rodrígues-Díez, R.; Rodrígues-Díez, R. R.; Rayego-Mateos, S.;
Suárez-Álvarez, B.; Lavoz, C.; Aroeira, L. S.; Sánchez-López, E.;
Orejudo, M.; Alique, M.; López-Larrea, C.; Ortiz, A.; Egido, J.;
Ruiz-Ortega, M. The C-terminal module IV of connective tissue
growth factor is a novel immune modulator of the Th17 response. LABORATORY INVESTIGATION. 2013; 93(7): 812-824.
3.828 Q1
2013 Álvarez-Lerma, F.; Gracia-Arnillas, M. P.; Palomar, M.; Olaechea,
P.; Insausti, J.; López-Pueyo, M. J.; Otal, J. J. ; Gimeno, R.; Seijas, I. (Peces, R.). Urethral catheter-related urinary infection in critical patients admitted to the ICU. Descriptive data of the ENVIN-UCI Study. MEDICINA INTENSIVA. 2013; 37(2): 75-82. Artículo.
1.24 Q4
2013 Portoles, J.; Janeiro, D.; Lou-Arnal, L. M.; López-Sánchez, P.; Ortega, M.; del Peso, G.; Felipe, C.; Tato, A. M.; Velo, M.; Castellano, I.; Pérez-Díaz, V. First episodes of peritoneal infection:
description and prognostic factors. NEFROLOGÍA. 2013; 33(3):
316-324. Artículo.
1.442 Q3
2013 Fernández-Reyes, L.; Bajo-Rubio, M. A. Is peritoneal kinetics useful in clinical practice? In favour. NEFROLOGÍA. 2013; 33(3): 416-423. Artículo. 1.442 Q3
2013 C.; Díez, J. J.; Iglesias, P.; González, E.; Aguilar-Rodríguez, A.;
Selgas, R.; Bajo, M. A. Repeated analysis of estimated insulin
resistance using the HOMAIR index in nondiabetic patients on
peritoneal dialysis and its relationship with cardiovascular disease
and mortality. NEFROLOGÍA. 2013; 33(1): 85-92. Artículo.
1.442 Q3
2013 de Sousa-Amorim, E.; Bajo-Rubio, M. A.; del Peso-Gilsanz, G.;
Castro, M. J.; Celadilla, O.; Selgas-Gutiérrez, R. Thirty years in a
peritoneal dialysis unit: long-term survival. NEFROLOGÍA. 2013;
33(4): 546-551. Artículo.
1.442 Q3
2013 Jiménez, C.; González, E.; Marqués, M.; Galeano, C.; Andrés, A.; Calvo, N.; Pascual, J. The impact of darbepoietin alfa in early post-transplant anaemia management: retrospective exploratory study. NEFROLOGÍA. 2013; 33(1): 107-115. Artículo. 1.442 Q3
2013 Pérez-Torres, A.; González, E.; Bajo, M. A.; Milla, S. P.; Sánchez-
Villanueva, R.; Bermejo, L. M.; del Peso, G.; Selgas, R.; Gómez-Candela, C. Evaluation of a nutritional intervention program in advanced chronic kidney disease (ACKD) patients NUTRICIÓN HOSPITALARIA. 2013; 28(6): 2252-2260. Artículo.
1.25 Q4
2013 Pérez, S. R.; Díez, J. J.; Bajo, M. A.; Iglesias, P.; Grande, C.; del
Peso, G.; Madero, R.; Ossorio, M.; Selgas, R. Thyrotropin and
free thyroxine concentrations do not affect cardiovascular
disease and mortality in euthyroid peritoneal dialysis patients.
PERITONEAL DIALYSIS INTERNATIONAL. 2013; 33(6): 697-700. Artículo.
2.199 Q2
2013 Pérez-Lozano, M. L.; Sandoval, P.; Rynne-Vidal, A.; Aguilera,
A.; Jiménez-Heffernan, J. A.; Albar-Vizcaíno, P.; Majano,
P. L.; Sánchez-Tomero, J. A.; Selgás, R.; López-Cabrera, M.
Functional relevance of the switch of VEGF receptors/coreceptors
during peritoneal dialysis-induced mesothelial to mesenchymal transition. PLOS ONE. 2013; 8(4): e60776. Artículo.
Q1 3.534
2013 Jankowski, V.; Tolle, M.; Tran, T. N. A.; van der Giet, M.; Schuchardt, M.; Lehmann, K.; Janke, D.; Flick, B.; Ortiz, A. A.; Sánchez, N. M. D.; Tepel, M.; Zidek, W.; Jankowski, J. Identification of a potent endothelium-derived angiogenic factor. PLOS ONE. 2013; 8(7): e68575. Artículo. 3.534 Q1
2013 Benito-Martín, A.; Ucero, A. C.; Zubiri, I.; Posada-Ayala, M.;
Fernández-Fernández, B.; Cannata-Ortiz, P.; Sánchez-Niño,
M. D.; Ruiz-Ortega, M.; Egido, J.; Álvarez-Llamas, G.; Ortiz, A.
Osteoprotegerin in exosome-like vesicles from human cultured
tubular cells and urine. PLOS ONE. 2013; 8(8): e72387. Artículo.
3.534 Q1
2013 Loureiro, J.; Sandoval, P.; del Peso, G.; González-Mateo, G.;
Fernández-Millara, V.; Santamaría, B.; Bajo, M. A.; Sánchez-
Tomero, J. A.; Guerra-Azcona, G.; Selgás, R.; López-Cabrera,
M.; Aguilera, A. I. Tamoxifen ameliorates peritoneal membrane
damage by blocking mesothelial to mesenchymal transition
in peritoneal dialysis. PLOS ONE. 2013; 8(4): e61165. Artículo.
3.534 Q1
2013 García-Llana, H.; Remor, E.; Selgas, R. Adherence to treatment,
emotional state and quality of life in patients with endstage renal disease undergoing dialysis. PSICOTHEMA. 2013; 25(1): 79-86. Artículo.
1.083 Q2
2013 Ramírez, E.; Jiménez, C.; Borobia, A. M.; Tong, H. Y.; Medrano,
N.; Krauel-Bidwell, L.; Carcas, A. J.; Selgás, R.; Frias, J. Vancomycin-induced acute kidney injury detected by a prospective
pharmacovigilance program from laboratory signals. THERAPEUTIC DRUG MONITORING. 2013; 35(3): 360-366. Artículo.
1.926. Q2
2013 Mazuecos, A.; Fernández, A.; Zarraga, S.; Andrés, A.; Rodríguez-
Benot, A.; Jiménez, C.; Gómez, E.; Paul, J.; Jimeno, L.; Fernández, C.; Burgos, D.; Sánchez-Fructuoso, A.; Guirado, L. High incidence of delayed graft function in HIV-infected kidney transplant recipients. TRANSPLANT INTERNATIONAL. 2013; 26(9): 893-902. Artículo.
3.12 Q1
2013 Pascual, J.; Jiménez, C.; Franco, A.; Gil, M.; Obrador-Mulet,
A. R.; Gentil, M. A.; Romero, R.; Grinyo, J. M.; Hernández, D.;
Morales, J. M.; Pallardo, L. M.; Serón, D.; Arias, M.; Campistol,
J. M. Early-onset anemia after kidney transplantation is an independent factor for graft loss: a multicenter, observational
cohort study. TRANSPLANTATION. 2013; 96(8): 717-725. Artículo.
3.535 D1
2013 Ortiz, A.; Sánchez-Niño, M. D. The demise of calcium-based phosphate binders. LANCET. 2013; 382(9900): 1232-1234. Material Editorial. 39.207 D1
2013 Iglesias, P.; Grande, C.; Cano, A. G.; Mauri, M. Anti-insulin
antibodies interference in the Siemens Immulite chemiluminescent
insulin immuno-assay. CLINICA CHIMICA ACTA. 2013; 425: 186-187. Carta.
2.764 Q1
2013 Vega-Cabrera, C.; Costero-Fernández, O.; Rivas-Becerra, B.;
Menéndez-González, D.; Selgas-Gutiérrez, R. Emphysematous
cystitis. NEFROLOGÍA. 2013; 33(1): 149-150. Carta.
1.442 Q3
2013 García-Llana, H.; Rodríguez-Rey, R.; Celadilla, O.; Bajo, A.; Sánchez-Villanueva, R.; del Peso, G.; González, E.; Trocoli, F.; Selgas, R. Nurse-psychologist interdisciplinary approach for advanced chronic kidney disease consultations: objectives and protocol. NEFROLOGÍA. 2013; 33(1): 139-140. Carta. 1.442 Q3
2013 Sánchez-Niño, M. D.; Ortiz, A. HCV Infection and miravirsen.
NEW ENGLAND JOURNAL OF MEDICINE. 2013; 369(9): 877-878. Carta.
54.42 D1
2013 Costero, O.; Sánchez-Recalde, A.; Moreno, R.; Moreno, I.; Selgas, R.; López-Sendón, J. L. Pseudopheochromocytoma as a cause of resistant and paroxysmal hypertension successfully treated by percutaneous renal denervation. REVISTA ESPAÑOLA DE CARDIOLOGÍA. 2013; 66(3): 227-229. Carta. 3.342 Q2
2013 Sánchez-Niño, M. D.; Sanz, A. B.; Ruiz-Andrés, O.; Poveda, J.;
Izquierdo, M. C.; Selgas, R.; Egido, J.; Ortiz, A. MIF, CD74 and
other partners in kidney disease: tales of a promiscuous couple.
CYTOKINE & GROWTH FACTOR REVIEWS. 2013; 24(1): 23-40. Revisión.
6.537 Q1
2013 Sanz, A. B.; Sánchez-Niño, M. D.; Martín-Cleary, C.; Ortiz, A.;
Ramos, A. M. Progress in the development of animal models
of acute kidney injury and its impact on drug discovery. EXPERT
OPINION ON DRUG DISCOVERY. 2013; 8(7): 879-895. Revisión.
3.467 Q1
2013 Iglesias, P.; Selgas, R.; Romero, S.; Díez, J. J. Selenium and kidney
disease. JOURNAL OF NEPHROLOGY. 2013; 26(2): 266-272.
1.996 Q2
2013 Herrero, J. A.; López-Gómez, J. M.; Maduell, F.; Martín-de Francisco, A. L.; Martín-Malo, A.; Martínez-Castelao, A.; Navarro-González, J. F.; Pérez-Fontán, M.; Pérez, J.; Selgas, R.; Solozabal, C. Activation of vitamin D receptors in the optimization
of hyperparathyroidism secondary to dialysis. NEFROLOGÍA.
2013; 33(4): 571-584. Revisión.
1.442 Q3
2012 Olea, T.; Díaz-Mancebo, R.; Picazo, M. L.; Martínez-Ara, J..;
Robles, A.; Selgas, R. Thrombotic microangiopathy associated
with use of interferon-beta. INTERNATIONAL JOURNAL
No tiene No tiene
2012 Sánchez-Niño, M. D.; Ortiz, A. Notch3 and kidney injury: never two without three. JOURNAL OF PATHOLOGY. 2012; 228(3): 266-273. Article. 7,585 D1
2012 Izquierdo, M. C.; Sanz, A. B.; Mezzano, S.; Blanco, J.; Carrasco,
S.; Sánchez-Niño, M. D.; Benito-Martín, A.; Ruiz-Ortega, M.; Egido, J.; Ortiz, A. TWEAK (tumor necrosis factor-like weak inducer of apoptosis) activates CXCL16 expression during renal tubulointerstitial infl ammation. KIDNEY INTERNATIONAL. 2012; 81(11): 1098-1107. Article.
7,916  D1
2012 Calleros, L.; Cortes, M. A.; Luengo, A.; Mora, I.; Guijarro, B.; Martín, P.; Ortiz-Arduán, A.; Selgas, R.; Rodríguez-Puyol, D.; Rodríguez-Puyol, M. Start-up of a clinical sample processing, storage and management platform: organisation and development of the REDinREN Biobank. NEFROLOGÍA. 2012; 32(1): 28-34. Article. 1,274 Q4
2012 Villa, G.; Fernández-Ortiz, L.; Cuervo, J.; Rebollo, P.; Selgas, R.;
González, T.; Arrieta, J. Cost-effectiveness analysis of the spanish
renal replacement therapy program. PERITONEAL DIALYSIS
INTERNATIONAL. 2012; 32(2): 192-199. Article.
 2,214 Q2
2012 Conde, E.; Alegre, L.; Blanco-Sánchez, I.; Sáenz-Morales, D.;
Aguado-Fraile, E.; Ponte, B.; Ramos, E.; Saiz, A.; Jiménez, C.;
Ordóñez, A.; López-Cabrera, M.; del Peso, L.; de Landázuri,
M. O.; Liano, F.; Selgas, R.; Sánchez-Tomero, J. A.; García-
Bermejo, M. L. Hypoxia inducible factor 1-Alpha (HIF-1 Alpha) is induced during reperfusion after renal ischemia and is critical for proximal tubule cell survival. PLOS ONE. 2012; 7(3): e33258. Article.
 3,73 Q1
2012 Sanz, A. B.; Sánchez-Niño, M. D.; Carrasco, S.; Manzarbeitia,
F.; Ruiz-Andres, O.; Selgas, R.; Ruiz-Ortega, M.; González-Enguita,
C.; Egido, J.; Ortiz, A. Infl ammatory cytokines and survival factors from serum modulate tweak-induced apoptosis in PC-3 prostate cancer cells. PLOS ONE. 2012; 7(10): e47440. Article.
 3,73  Q1
2012 Sánchez-Niño, M. D.; Sanz, A. B.; Ortiz, A. Uromodulin, infl
ammasomes, and pyroptosis. JOURNAL OF THE AMERICAN
SOCIETY OF NEPHROLOGY. 2012; 23(11): 1761-1763. Editorial Material.
8,987 D1
2012 Díaz-Mancebo, R.; Costero-Fernández, O.; Vega-Cabrera, C.; Olea-Tejero, T.; Yébenes, L.; Picazo, M. L.; Selgas-Gutiérrez,
R. DRESS syndrome and acute tubulointerstitial nephritis after treatment with vancomycin and beta-lactam. Case report and literature review. NEFROLOGÍA. 2012; 32(5): 685-687. Letter.
1,274 Q4
2012 Arrieta, J.; Rodríguez-Carmona, A.; Remón, C.; Pérez-Fontán,
M.; Ortega, F.; Sánchez-Tomero, J. A.; Selgas, R. Cost comparison between haemodialysis and peritoneal dialysis outsourcing agreements. NEFROLOGÍA. 2012; 32(2): 247-248. Letter.
1,274 Q4
2012 Ortiz, A.; Sánchez-Niño, M. D. The human plasma lipidome.
NEW ENGLAND JOURNAL OF MEDICINE. 2012; 366(7): 668-669. Letter.
51,658 D1
2012 Elewa, U.; Sánchez-Niño, M. D.; Martín-Cleary, C.; Fernández-
Fernández, B.; Egido, J.; Ortiz, A. Cardiovascular risk
biomarkers in CKD: the infl ammation link and the road less
2012; 44(6): 1731-1744. Review.
1,325  Q3
2012 Izquierdo, M. C.; Sanz, A. B.; Sánchez-Niño, M. D.; Pérez-
Gómez, M. V.; Ruiz-Ortega, M.; Poveda, J.; Ruiz-Andrés, O.;
Ramos, A. M.; Moreno, J. A.; Egido, J.; Ortiz, A. Acute kidney
injury transcriptomics unveils a relationship between infl ammation and ageing. NEFROLOGÍA. 2012; 32(6): 715-723. Review.
1,274 Q4
2012 Izquierdo, M. C.; Pérez-Gómez, M. V.; Sánchez-Niño, M. D.;
Sanz, A. B.; Ruiz-Andrés, O.; Poveda, J.; Moreno, J. A.; Egido,
J.; Ortiz, A. Klotho, phosphate and infl ammation/ageing in chronic kidney disease. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2012; 27(4): iv6-iv10. Review.
3,371 Q1
2012 Tessitore, N.; Santoro, A.; Panzetta, G. O.; Wizemann, V.; Pérez-García, R.; Ara, J. M.; Perrone, B.; Mantovani, W.; Poli, A. Acetate-free biofi ltration reduces intradialytic hypotension: a european multicenter randomized controlled trial. BLOOD PURIFICATION. 2012; 34(03 abr): 354-363. Article. 2,062 Q2
2012 Gutiérrez, E.; Zamora, I.; Ballarín, J. A.; Arce, Y.; Jiménez, S.;
Quereda, C.; Olea, T.; Martínez-Ara, J.; Segarra, A.; Bernis,
C.; García, A.; Goicoechea, M.; de Vinuesa, S, G.; Rojas-Rivera,
J.; Praga, M, Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2012; 23810): 1753-1760. Article.
8,987 D1
2012 Tortajada, A.; Pinto, S.; Martínez-Ara, J.; López-Trascasa, M.; Sánchez-Corral, P.; de Córdoba, S. R. Complement factor H variants I890 and L1007 while commonly associated with atypical hemolytic uremic syndrome are polymorphisms with no functional signifi cance. KIDNEY INTERNATIONAL. 2012; 81(1): 56-63. Article. 7,916 D1
2012 Fernández, B. F.; Elewa, U.; Sánchez-Niño, M. D.; Rojas-Rivera,
J. E.; Martín-Cleary, C.; Egido, J.; Ortiz, A. 2012 update on diabetic kidney disease: the expanding spectrum, novel pathogenic insights and recent clinical trials. MINERVA MÉDICA. 2012; 103(4): 219-234. Article.
0,771 Q3
2012 Peces, R.; Aguilar, A.; Vega, C.; Cuesta, E.; Peces, C.; Selgas,
R. Medical therapy with tranexamic acid in autosomal dominant
polycystic kidney disease patients with severe haematuria. NEFROLOGÍA. 2012; 32(2): 160-165. Article.
1,274 Q4
2012 Peces, R.; Vega, C.; Aguilar, A.; Zometa, R.; Tapia, C.; Peces,
C.; Cuesta, E. Autosomal dominant polycystic kidney disease
with contralateral renal agenesis. NEFROLOGÍA. 2012; 32(6):
839-842. Letter.
 1,274 Q4
2012 Leiva-Santos, J. P.; Sánchez-Hernández, R.; García-Llana, H.; Fernández-Reyes, M. J.; Heras-Benito, M.; Molina-Ordas, A.; Rodríguez, A.; Álvarez-Ude, F. Renal supportive care and renal palliative care: revision and proposal in kidney replacement therapy. NEFROLOGÍA. 2012; 32(1): 20-27. Review. 1,274 Q4
2012 Herrero-Calvo, J. A.; González-Parra, E.; Pérez-García, R.; Tornero-Molina, F. (Martínez Ara, J.). Spanish study of  anticoagulation in haemodialysis. NEFROLOGÍA. 2012; 32(2):143-
152. Article.
1,274 Q4
2012 del Peso, G.; Bajo, M. A.; Fontán, M. P.; Martínez, J.; Marrón,
B.; Selgas, R. Effect of self-administered intraperitoneal bemiparin
on peritoneal transport and ultrafi ltration capacity in peritoneal dialysis patients with membrane dysfunction. A randomized, multi-centre open clinical trial. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2012; 27(5): 2051-2058. Article. 
3,371 Q1
2012 Portoles, J.; López-Sánchez, P.; Bajo, M. A.; Castellano, I.; del
Peso, G.; Rodríguez, J. R.; Ribera, M.; Ortigosa, A.; Selgas, R.
Cinacalcet improves control of secondary hyperparathyroidism in peritoneal dialysis: a multicenter study. PERITONEAL DIALYSIS INTERNATIONAL. 2012; 32(2): 208-2011. Article.
 2,214 Q2
2012 Fernández-Perpén, A.; Pérez-Lozano, M. L.; Bajo, M. A.; Albar-Vizcaíno, P.; Correa, P. S.; del Peso, G.; Castro, M. J.; Aguilera, A.; Ossorio, M.; Peter, M. E.; Passlick-Deetjen, J.; Aroeira, L. S.; Selgas, R.; López-Cabrera, M.; Sánchez-Tomero, J. A. Infl uence of bicarbonate/low-GDP peritoneal dialysis fl uid (BICAVERA) on in vitro and ex vivo epithelial-tomesenchymal transition of mesothelial cells. PERITONEAL DIALYSIS INTERNATIONAL. 2012; 32(3): 292-304. Article. 2,214 Q2
2012 Fernández-Reyes, M. J.; Bajo, M. A.; del Peso, G.; Ossorio, M.; Díaz, R.; Carretero, B.; Selgas, R. The infl uence of initial peritoneal transport characteristics, infl ammation, and high glucose exposure on prognosis for peritoneal membrane function. PERITONEAL DIALYSIS INTERNATIONAL. 2012; 32(6): 363-644. Article.  2,214 Q2
2012 Bernardo, A. P.; Bajo, M. A.; Santos, O.; del Peso, G.; Carvalho,
M. J.; Cabrita, A.; Selgas, R.; Rodrigues, A. Two-inone protocol: simultaneous small-pore and ultrasmall-pore peritoneal transport quantifi cation. PERITONEAL DIALYSIS INTERNATIONAL. 2012; 32(5): 537-544. Article.
2,214 Q2
2012 Strippoli, R.; Benedicto, I.; Lozano, M. L. P.; Pellinen, T.; Sandoval, P.; López-Cabrera, M.; del Pozo, M. A. Inhibition of transforming growth factor-activated kinase 1 (TAK1) blocks and reverses epithelial to mesenchymal transition of mesothelial cells. PLOS ONE. 2012; 7(2): e31492. Article.  3,73 Q1
2012 González-Mateo, G. T.; Aroeira, L. S.; López-Cabrera, M.; Ruiz-Ortega, M.; Ortiz, A.; Selgas, R. Pharmacological modulation of peritoneal injury induced by dialysis fl uids: is it an option? NEPHROLOGY DIALYSIS TRANSPLANTATION. 2012; 27(2): 478-481. Editorial Material. 3,371 Q1
2012 de Sousa-Amorim, E.; del Peso-Gilsanz, G.; Bajo-Rubio, M.A.; Selgas-Gutiérrez, R. Asymptomatic polyostotic Paget’s disease associated with secondary hyperparathyroidism in a peritoneal dialysis patient. NEFROLOGÍA. 2012; 32(4): 542-544. Letter. 1,274 Q4
2012 Díaz-Mancebo, R.; Sánchez-Villanueva, R.; González-García, E.; Ossorio-González, M.; Selgas-Gutiérrez, R. Nephrogenic ascites: a thing of the past? NEFROLOGÍA. 2012; 32(3): 406-408. Letter.  1,274 Q4
2012 Iglesias, P.; Selgas, R.; Romero, S.; Díez, J. J. Biological role, clinical signifi cance, and therapeutic possibilities of the recently discovered metabolic hormone fi broblastic growth factor 21. EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2012; 167(3): 301-309. Review. 3,136  Q2
2012 de Sousa, E.; del Peso-Gilsanz, G.; Bajo-Rubio, M. A.; Ossorio-
González, M.; Selgas-Gutiérrez, R. Encapsulating peritoneal sclerosis in peritoneal dialysis. A review and european initiative for approaching a serious and rare disease. NEFROLOGÍA. 2012; 32(6): 707-714. Review.
1,274 Q4
2012 Sánchez-Fructuoso, A. I.; Ruiz, J. C.; Torregrosa, J. V.; González,
E.; Gómez, E.; Gallego, R. J.; Troya, M. I.; Jiménez, C.; Llamas, F.; Romero, R.; Bernis, C.; Crespo, J, F.; Guirado, L, Anemia control in renal transplant recipients receiving continuous erythropoietin receptor activator (C.E.R.A.) treatment: the AnemiaTrans Study. ADVANCES IN THERAPY. 2012; 29(11): 979-991. Article. 
2,125 Q3
2012 Tavira, B.; Coto, E.; Torres, A.; Díaz-Corte, C.; Díaz-Molina, B.;
Ortega, F.; Arias, M.; Díaz, J. M.; Selgas, R.; López-Larrea, C.;
Ruiz-Ortega, M.; Ortiz, A.; González, E.; Campistol, J. M.; Álvarez,
V. Association between a common KCNJ11 polymorphism
(rs5219) and new-onset posttransplant diabetes in patients
treated with Tacrolimus. MOLECULAR GENETICS AND
METABOLISM. 2012; 105(3): 525-527. Article.
 2,834 Q2
2012 Pascual, J.; Alonso, A.; Burgos, D.; Cruzado, J. M.; Serón, D. (Escuín F.). Chronic renal dysfunction in renal transplant patient recipients. Consensus ocument. NEFROLOGÍA. 2012; 32(2): 1-28. Article. 1,274 Q4
2012 Morales, J. M.; Marcén, R.; del Castillo, D.; Andrés, A.; González-
Molina, M.; Oppenheimer, F.; Serón, D.; Gil-Vernet, S.; Lampreave, I.; Gainza, F. J.; Valdés, F.; Cabello, M.; Anaya, F.; Escuín, F.; Arias, M.; Pallardo, L.; Bustamante, J, Risk factors for graft loss and mortality after renal transplantation according to recipient age: a prospective multicentre study, NEPHROLOGY DIALYSIS TRANSPLANTATION. 2012; 27(4): iv39-iv46. Article.
 3,371 Q1
2011 Ortiz, A.; Sánchez-Niño, M. D.; Izquierdo, M. C.; Blanco-Colio, L. M.; Selgas, R.; Ruiz-Ortega, M.; Egido, J.; Sanz, A. B. TWEAK and the Kidney: the Dual Role of a Multifunctional Cytokine. ADVANCES IN TNF FAMILY RESEARCH. 2011; 691: 323-335. Article. N/A N/A
2011 Sanz, A. B.; Sánchez-Niño, M. D.; Ortiz, A. TWEAK, a multifunctional cytokine in kidney injury. KIDNEY INTERNATIONAL. 2011; 80(7): 708-718. Review. 6,606 D1
2011 Suárez-Fueyo, A.; Barber, D. F.; Martínez-Ara, J.; Zea-Mendoza, A. C.; Carrera, A. C. Enhanced Phosphoinositide 3-Kinase delta Activity Is a Frequent Event in Systemic Lupus Erythematosus That Confers Resistance to Activation-Induced T Cell Death. JOURNAL OF IMMUNOLOGY. 2011; 187(5): 2376-2385. Article. 5,788 Q1
2011 Moreno, J. A.; Izquierdo, M. C.; Sánchez-Niño, M. D.; Suárez-Álvarez, B.; López-Larrea, C.; Jakubowski, A.; Blanco, J.; Ramírez, R.; Selgas, R.; Ruiz-Ortega, M.; Egido, J.; Ortiz, A.; Sanz, A. B. The Inflammatory Cytokines TWEAK and TNF alpha Reduce Renal Klotho Expression through NF kappa B. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2011; 22(7): 1315-1325. Article. 9,663 D1
2011 Peces, R.; de Sousa, E.; Peces, C. Renal biopsy in special situations. NEFROLOGIA. 2011; 31(6): 627-629. Editorial Material. 1 Q4
2011 Peces, R.; Peces, C. Autosomal dominant polycystic kidney disease and sickle cell trait. NEFROLOGÍA. 2011; 31(2): 134-136. Editorial Material. 1 Q4
2011 Peces, R.; Peces, C.; Cuesta-López, E.; Vega-Cabrera, C.; Azorín, S.; Pérez-Dueñas, V.; Selgas, R. Co-inheritance of autosomal dominant polycystic kidney disease and sickle-cell trait in African Americans. NEFROLOGÍA. 2011; 31(2): 162-168. Article. 1 Q4
2011 Peces, R.; Cuesta-López, E.; Peces, C.; Selgas, R. Giant Bilateral
Renal Angiomyolipomas and Lymphangioleiomyomatosis Presenting after Two Successive Pregnancies Successfully Treated with Surgery and Rapamycin. THESCIENTIFICWORLDJOURNAL. 2011; 11: 2115-2123. Article.
2011 Peces, R.; Cuesta-López, E.; Peces, C.; Pérez-Dueñas, V.; Vega-Cabrera, C.; Selgas, R. Octreotide reduces hepatic, renal and breast cystic volume in autosomal-dominant polycystic kidney disease. INTERNATIONAL UROLOGY AND NEPHROLOGY. 2011; 43(2): 565-569. Article. 1,471 Q3
2011 García-Llana, H.; Barbero, J.; Remor, E.; Díaz-Sayas, L.; Rodríguez-Rey, R.; del Peso, G.; Selgas, R. Impact of an interdisciplinary training program in Counselling and decision-making process in a nephrology department. NEFROLOGÍA. 2011; 31(3): 322-330. Article. 1 Q4
2011 Bernardo, A. P.; Contesse, S. A.; Bajo, M. A.; Rodrigues, A.; Del
Peso, G.; Ossorio, M.; Cabrita, A.; Selgas, R. Peritoneal Membrane Phosphate Transport Status: A Cornerstone in Phosphate Handling in Peritoneal Dialysis. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2011; 6(3): 591-597. Article.
5,227 D1
2011 Bellón, T.; Martínez, V.; Lucendo, B.; del Peso, G.; Castro, M. J.; Aroeira, L. S.; Rodríguez-Sanz, A.; Ossorio, M.; Sánchez-Villanueva, R.; Selgas, R.; Bajo, M. A. Alternative activation of macrophages in human peritoneum: implications for peritoneal fibrosis. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2011; 26(9): 2995-3005. Article. 3,396 Q1
2011 Bajo, M. A.; Pérez-Lozano, M. L.; Albar-Vizcaíno, P.; del Peso, G.; Castro, M. J.; González-Mateo, G.; Fernández-Perpén, A.; Aguilera, A.; Sánchez-Villanueva, R.; Sánchez-Tomero, J. A.; López-Cabrera, M.; Peter, M. E.; Passlick-Deetjen, J.; Selgas, R. Low-GDP peritoneal dialysis fluid (‘balance’) has less impact in vitro and ex vivo on epithelialto-mesenchymal transition (EMT) of mesothelial cells than a standard fluid. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2011;
26(1): 282-291. Article.
3,396 Q1
2011 Díez, J. J.; Bossola, M.; Fernández-Reyes, M. J.; di Stasio, E.; Tazza, L.; Luciani, G.; Codoceo, R.; Iglesias, P.; Rodríguez, A.; González, E.; Selgas, R. Relationship between leptin and all-cause and cardiovascular mortality in chronic hemodialysis patients. NEFROLOGÍA. 2011; 31(2): 206-212. Article. 1 Q4
2011 Trullas, J. C.; Cofán, F.; Barril, G.; Martínez-Castelao, A.; Jofre, R.; Rivera, M.; Martínez-Ara, J.; Ros, S.; Pérez, I.; Moreno, A.; Miro, J. M. Outcome and Prognostic Factors in HIV-1-Infected Patients on Dialysis in the cART Era: a GESIDA/SEN Cohort Study. JAIDSJOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2011; 57(4): 276-283. Article. 4,425 Q1
2011 Mancebo, R. D.; Gilsanz, G. D.; Rodríguez, M.; Fernández, B.; González, M. O.; Rubio, M. A. B.; Gutiérrez, R. S. Pleuroperitoneal communication in patients on peritoneal dialysis. One hospital’s experience and a review of the literature. NEFROLOGIA. 2011; 31(2): 213-217. Review. 1 Q4
2011 Loureiro, J.; Aguilera, A.; Selgas, R.; Sandoval, P.; Albar-Vizcaíno, P.; Pérez-Lozano, M. L.; Ruiz-Carpio, V.; Majano, P. L.; Lamas, S.; Rodríguez-Pascual, F.; Borras-Cuesta, F.; Dotor, J.; López-Cabrera, M. Blocking TGF-beta 1 Protects the Peritoneal Membrane from Dialysate-Induced Damage. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2011; 22(9): 1682-1695. Article. 9,663 D1
2011 Tavira, B.; García, E. C.; Díaz-Corte, C.; Ortega, F.; Arias, M.; Torres, A.; Díaz, J. M.; Selgas, R.; López-Larrea, C.; Campistol, J. M.; Alvarezca, V. Pharmacogenetics of tacrolimus after renal transplantation: analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes. CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2011; 49(5): 825-833. Article. 2,15 Q2
2011 Tavira, B.; Coto, E.; Díaz-Corte, C.; Ortega, F.; Arias, M.; Torres, A.; Díaz, J. M.; Selgas, R.; López-Larrea, C.; Campistol, J. M.; Ruiz-Ortega, M.; Álvarez, V. KCNQ1 gene variants and risk of new-onset diabetes in tacrolimus-treated renal-transplanted patients. CLINICAL TRANSPLANTATION. 2011; 25(3): E284-E291. Article. 1,667 Q2
2011 Portoles, J.; Moreno, F.; López-Sánchez, P.; Mancha, J.; Gómez, M.; Corchete, E.; del Peso, G.; Bajo, M. A.; Llópez-Carratala, R.; Fernández-Perpén, A. Peritoneal dialysis and kidney transplant. A two-way ticket in an integrated renal replacement therapy model. NEFROLOGÍA. 2011; 31(4): 441-448. Article. 1 Q4
2010 Fernández-Reyes, M. J.; Díez, J. J.; Collado, A.; Iglesias, P.; Bajo, M. A.; Estrada, P.; del Peso, G.; Heras, M.; Molina, A.; Selgas, R. Are low concentrations of serum triiodothyronine a good marker for long-term mortality in hemodialysis patients? CLINICAL NEPHROLOGY. 2010; 73(3): 238-240. Article. 1,058 Q4.
2010 Costero, O.; Picazo, M. L.; Zamora, P.; Romero, S.; Martínez-Ara, J.; Selgas, R. Inhibition of tyrosine kinases by sunitinib associated with focal segmental glomerulosclerosis lesion in addition to thrombotic microangiopathy. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2010; 25(3): 1001-1003. Article. 3,564 Q1
2010 Merino, A.; Portoles, J.; Selgas, R.; Ojeda, R.; Buendía, P.; Ocana, J.; Bajo, M. A.; del Peso, G.; Carracedo, J.; Ramírez, R.; Martín-Malo, A.; Aljama, P. Effect of Different Dialysis Modalities on Microinflammatory Status and Endothelial Damage. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2010; 5(2): 227-234. Article. 4,763 Q1
2010 Sanz, A. B.; Sánchez-Niño, M. D.; Izquierdo, M. C.; Jakubowski, A.; Justo, P.; Blanco-Colio, L. M.; Ruiz-Ortega, M.; Selgas, R.; Egido, J.; Ortiz, A. TWEAK Activates the Non-Canonical NF kappa B Pathway in Murine Renal Tubular Cells: Modulation of CCL21. PLOS ONE. 2010; 5(1): e8955. Article. 4,411 Q1
2010 Bajo, M. A.; Selgas, R.; Remón, C.; Arrieta, J.; Álvarez-Ude, F.; Arenas, M. D.; Borras, M.; Coronel, F.; García-Ramón, R.; Minguela, I.; Pérez-Banasco, V.; Pérez-Contreras, J.; Fontán, M. P.; Teixido, J.; Tornero, F.; Vega, N. Scientific-technical quality and ongoing quality improvement plan in peritoneal diálisis. NEFROLOGÍA. 2010; 30(1): 28-45. Article. 0,738 Q4
2010 Peces, R.; Azorín, S.; Peces, C.; Selgas, R. Extended hemoperfusion in the treatment of acute carbamazepine intoxication. NEFROLOGÍA. 2010; 30(1):127-130. Article. 0,738 Q4
2010 Gómez, M. P. R.; García-Perea, A.; Carrascoso, G. R.; Bajo, M. A.; Mingorance, J. Campylobacter fetus Peritonitis and Bacteremia in a Patient Undergoing Continuous Ambulatory Peritoneal Diálisis. JOURNAL OF CLINICAL MICROBIOLOGY. 2010; 48(1): 336-337. Article. 4,22 Q1
2010 Loureiro, J.; Schilte, M.; Aguilera, A.; Albar-Vizcaino, P.; Ramírez-Huesca, M.; Pérez-Lozano, M. L.; González-Mateo, G.; Aroeira, L. S.; Selgas, R.; Mendoza, L.; Ortiz, A.; Ruiz-Ortega, M.; van den Born, J.; Beelen, R. H. J.; López-Cabrera, M. BMP-7 blocks mesenchymal conversion of mesothelial cells and prevents peritoneal damage induced by dialysis fluid exposure. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2010; 25(4): 1098-1108. Article. 3,564 Q1
2010 García-Llana, H.; Barbero, J.; Olea, T.; Jiménez, C.; del Peso, G.; Miguel, J. L.; Sánchez, R.; Celadilla, O.; Trocoli, F.; Arguello, M. T.; Selgas, R. Incorporation of a psychologist into a nephrology service: criteria and process. NEFROLOGIA. 2010; 30(3): 297-303. Article. 0,738 Q4
2010 Fernández-Reyes, M. J.; Rubio, M. A. B.; Gilsanz, G. D. P.; Estrada, P.; Sousa, S.; Sánchez-Villanueva, R.; Heras, M.; Osorio, M.; Vega, C.; Selgas, R. The peritoneal kinetic study performed with hypertonic glucose permits better evaluation of UF capacity and determination of sieving of sodium. NEFROLOGÍA. 2010; 30(2): 208-213. Article. 0,738 Q4
2010 Peces, R.; Peces, C.; Cuesta-López, E.; Pérez-Dueñas, V.; Vega-Cabrera, C.; Azorín, S.; Selgas, R. Low-dose rapamycin reduces kidney volume angiomyolipomas and prevents the loss of renal function in a patient with tuberous sclerosis complex. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2010; 25(11): 3787-3791. Article. 3,564 Q1
2010 Sandoval, P.; Loureiro, J.; González-Mateo, G.; Pérez-Lozano, M. L.; Maldonado-Rodríguez, A.; Sánchez-Tomero, J. A.; Mendoza, L.; Santamaría, B.; Ortiz, A.; Ruiz-Ortega, M.; Selgas, R.; Martín, P.; Sánchez-Madrid, F.; Aguilera, A.; López-Cabrera, M. PPAR-gamma agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage. LABORATORY INVESTIGATION. 2010; 90(10): 1517-1532. Article. 4,405 Q1
2010 Portoles, J.; Ocaña, J.; López-Sánchez, P.; Gómez, M.; Rivera, M. T.; del Peso, G.; Corchete, E.; Bajo, M. A.; Rodríguez-Palomares, J. R.; Fernández-Perpén, A.; López-Gómez, J. M. Approach to quality objectives in incidents of patients in peritoneal dialysis. NEFROLOGÍA. 2010; 30(5): 544-551. Article. 0,738 Q4
2010 Peces, R.; Vega, C.; Peces, C.; Trebol, J.; González, J. A. Massive gastric dilatation and anuria resolved with naso-gastric tube decompression. INTERNATIONAL UROLOGY AND NEPHROLOGY. 2010; 42(3): 831-834. Article. 1,567 Q3
2010 García, E. G.; Del Peso, G.; Celadilla, O.; Castro, M. J.; Martínez, V.; Muñoz, I.; Sánchez-Villanueva, R.; de Guevara, C. L.; Selgas, R.; Bajo, M. A. Efficacy of Sodium Hypochlorite in Eradicating Hepatitis C Virus (HCV)-RNA from the Peritoneal Effluent of PD Patients. PERITONEAL DIALYSIS INTERNATIONAL. 2010; 30(6): 644-646. Article. 1,477 Q3
2010 Aguilera, A.; González-Espinoza, L.; Codoceo, R.; Jara, M. C.; Pavone, M.; Bajo, M. A.; Del Peso, G.; Celadilla, O.; Martínez, M. V.; López-Cabrera, M.; Selgas, R. Bowel bacterial overgrowth as another cause of malnutrition, inflammation, and atherosclerosis syndrome in peritoneal dialysis patients. ADVANCES IN PERITONEAL DIALYSIS. 2010; 26:130-6. Article. N/A N/A
2010 Carrera, F., Lok, C. E.; de Francisco, A.; Locatelli, F.; Mann, J. F.; Canaud, B.; Kerr, P. G.; Macdougall, I. C.; Besarab, A.; Villa, G.; Kazes, I.; Van Vlem, B.; Jolly, S.; Beber, U.; Dougherty, F. C.; PATRONUS Investigators. Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trial. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2010; 25(12): 4009-4017. Article. 3,564 Q1
2010 Barril, G.; Bartolomé, J.; Sanz, P.; Buoncristiani, E.; Traver, J. A.; Selgas, R.; Buoncristiani, U.; Castillo, I.; Quiroga, J. A.; Carreño, V. Effect of hemodialysis schedules and membranes on hepatocyte growth factor and hepatitis C virus RNA levels. JOURNAL OF MEDICAL VIROLOGY. 2010; 82(5): 763-767. Article. 2,895 Q2
2010 Guirado, L.; Ruiz, J. C.; Andrés, A.; Rengel, M.; Escuín, F.; Ortega, F.; Romero, R.; Díaz, J. M.; Beneyto, I.; Morales, J. M.; For the Spanish Group of Study of Chronic Allograft Nephropathy. Results of renal re-transplant in Spain (1990-2002). NDT PLUS. 2010; 3(Suppl_2): ii37-ii40. Article. N/A N/A
2010 Moreso, F.; Alonso, A.; Gentil, M. A.; González-Molina, M.; Capdevila, L.; Marcén, R.; Pascual, J.; Serón D.; Spanish Late Allograft Dysfunction Study Group (Escuín F). Improvement in late renal allograft survival between 1990 and 2002 in Spain: results from a multicentre case-control study. TRANSPLANT INTERNATIONAL. 2010; 23(9): 907-913. Artilce. 3,211 Q1
2010 Moreso, F.; Calvo, N.; Pascual, J.; Anaya, F.; Jiménez, C.; Del Castillo, D.; Sánchez-Plumed, J.; Serón, D. Early statin use is an independent predictor of long-term graft survival. NDT PLUS. 2010; 3(Suppl_2): ii26-ii31. Article. N/A N/A
2010 Gómez-Alamillo, C.; Fernández-Fresnedo, G.; Ortega, F.; Campistol, J. M.; Gentil, M. A.; Arias, M.; Investigators of ARES Study (Olea T). Erythropoietin resistance as surrogate marker of graft and patient survival in renal transplantation: 3-year prospective multicenter study. TRANSPLANTATION PROCEEDINGS. 2010; 42(8): 2935-2937. Article. 0.933 Q3
2010 Montejo, J. D.; Bajo, M. A.; del Peso, G.; Selgas, R. Role played by peritoneal dialysis in treating refractory heart failure. NEFROLOGÍA. 2010; 30(1): 21-27. Review. 0,738 Q4
Peces, R.; Vega-Cabrera, C.; Peces, C.; Pobes, A.; Fresno, M. F. MALT B cell lymphoma with kidney damage and monoclonal gammopathy: A case study and literature review. NEFROLOGÍA. 2010; 30(6): 681-686. Review.
0,738 Q4
2010 Sánchez-Niño; M. D.; Benito-Martín, A.; Gonçalves, S.; Sanz, A. B.; Ucero, A. C.; Izquierdo, M. C.; Ramos, A. M.; Berzal, S.; Selgas, R.; Ruiz-Ortega, M.; Egido, J.; Ortiz, A. TNF superfamily: a growing saga of kidney injury modulators. MEDIATORS OF INFLAMMATION. 2010; 182958. Review. 2,059 Q3
2010 Selgas, R.; Del Peso, G.; Bajo, M. A. Intra-abdominal hypertension favors ascites. PERITONEAL DIALYSIS INTERNATIONAL. 2010; 30(2): 156-157. Editorial Material. 1,477 Q3
2010 Hevia Ojanguren, C.; Bajo Rubio, M. A; Cirugeda García, A.; Fernández Perlen, A.; del Peso Gilsanz, G.; Sánchez Tomero, J. A; Selgas Gutiérrez, R. S. Ten-year experience in intensive theoretical-practical course of ongoing training in Peritoneal Dialysis. NEFROLOGÍA. 2010; 30(1): 132-133. Letter. 0,738 Q4
2010 Selgas, R. Clinical recommendations: an opportunity to introduce research from research networks using scientific societies. NEFROLOGÍA. 2010; 30(3): 368-368. Letter. 0,738 Q4
2009 Diez, JJ; Estrada, P; Bajo, MA; Fernandez-Reyes, MJ; Grande, C; del Peso, G; Heras, M; Molina, A; Iglesias, P; Sanchez-Villanueva, R; Selgas, R. High Stable Serum Adiponectin Levels Are Associated with a Better Outcome in Prevalent Dialysis Patients. AMERICAN JOURNAL OF NEPHROLOGY. 2009; 30(3): 244-252 3,481
2009 Rioboo, JP; Sanchez-Iriso, E; Ruano-Ravina, A; Lema, MLV; Sanchez-Guisande, D; Gonzalez-Rodriguez, L; Herrero, JA; Barril, G; Maduell, F; Hernandez, J; Otero, A; Bajo, MA; Sanchez, R. Short Daily versus Conventional Hemodialysis Quality of Life: A Cross-Sectional Multicentric Study in Spain. BLOOD PURIFICATION. 2009; 28(3): 159-164 1,893
2009 MA Bajo, G del Peso, R Selgas.. Prevención de la esclerosis peritoneal encapsulante en pacientes en diálisis peritoneal. DIALISIS Y TRASPLANTE. 2009; 30: 52-56 N/A
2009 Sanchez-Lopez, E; Rayego, S; Rodrigues-Diez, R; Rodriguez, JS; Rodrigues-Diez, R; Rodriguez-Vita, J; Carvajal, G; Aroeira, LS; Selgas, R; Mezzano, SA; Ortiz, A; Egido, J; Ruiz-Ortega, M. CTGF Promotes Inflammatory Cell Infiltration of the Renal Interstitium by Activating NF-kappa B. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2009; 20(7): 1513-1526 7,689
2009 Aroeira, LS; Lara-Pezzi, E; Loureiro, J; Aguilera, A; Ramirez-Huesca, M; Gonzalez-Mateo, G; Perez-Lozano, ML; Albar-Vizcaino, P; Bajo, MA; del Peso, G; Sanchez-Tomero, JA; Jimenez-Heffernan, JA; Selgas, R; Lopez-Cabrera, M. Cyclooxygenase-2 Mediates Dialysate-Induced Alterations of the Peritoneal Membrane. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2009; 20(3): 582-592 7,689
2009 Bajo, MA; Fontan, MP; Remon, C; Sanchez-Tomero, JA; Llados, F; Selgas, R. Changing the frequency of administration of darbepoetin alfa (from weekly to fortnightly) maintains the haemoglobin levels in patients undergoing peritoneal dialysis. NEFROLOGIA. 2009; 29(2): 136-142 0,533
2009 Sanchez-Lopez, E; Diez, RR; Vita, JR; Mateos, SR; Diez, RRR; Garcia, ER; Barria, CL; Mezzano, S; Egido, J; Ortiz, A; Ruiz-Ortega, M; Selgas, R. Connective tissue growth factor (CTGF): a key factor in the onset and progression of kidney damage. NEFROLOGIA. 2009; 29(5): 382-391 0,533
2009 Fernandez-Reyes, MJ; Bajo, MA; del Peso, G; Olea, T; Sanchez-Villanueva, RI; Gonzalez, E; Heras, M; Sanchez, R; Selgas, R. Effect of using icodextrin as a starting therapy for peritoneal permeability. NEFROLOGIA. 2009; 29(2): 130-135 0,533
2009 Peces, R; Cabrera, CV; Peces, C; Campos, I. Massive hepatic haematoma in patient on haemodialysis. NEFROLOGIA. 2009; 29(3): 279-281 0,533
2009 Portoles, J; Corchete, E; Lopez-Sanchez, P; Coronel, F; Ocana, J; Ortiz, A. Patients on peritoneal dialysis with type 2 diabetes present poorer progress than non-diabetics at the expense of their cardiovascular comorbidity. NEFROLOGIA. 2009; 29(4): 336-342 0,533
2009 Peces, R; Peces, C; Benitez, AL; Villanueva, RS; Cuesta, E. Pregnant patient with acute pyelonephritis and renal corticomedullary abcess: ultrasound and MRI imaging. NEFROLOGIA. 2009; 29(5): 492-494 0,533
2009 Gonzalez,E.;Praga,M.;Grupo Madrileno de Nefritis Intersticiales. When to use steroid treatment for those patients with drug-induced acute interstitial nephritis? NEFROLOGIA. 2009; 29(2): 95-98 0,533
2009 Perez-Garcia, R; Martin-Malo, A; Fort, J; Cuevas, X; Llados, F; Lozano, J; Garcia, F. Baseline characteristics of an incident haemodialysis population in Spain: results from ANSWER-025EFa multicentre, prospective, observational cohort study. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2009; 24(2): 578-588 3,306
2009 Evenepoel, P; Selgas, R; Caputo, F; Foggensteiner, L; Heaf, JG; Ortiz, A; Kelly, A; Chasan-Taber, S; Duggal, A; Fan, S. Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2009; 24(1): 278-285 3,306
2009 Sanchez-Villanueva, R; Bajo, A; del Peso, G; Fernandez-Reyes, MJ; Gonzalez, E; Romero, S; Estrada, P; Selgas, R. Higher daily peritoneal protein clearance when initiating peritoneal dialysis is independently associated with peripheral arterial disease (PAD): A possible new marker of systemic endothelial dysfunction ?. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2009; 24(3): 1009-1014 3,306
2009 Gonzalez-Mateo, GT; Loureiro, J; Jimenez-Hefferman, JA; Bajo, MA; Selgas, R; Lopez-Cabrera, M; Aroeira, LS. Chronic Exposure of Mouse Peritoneum to Peritoneal Dialysis Fluid: Structural and Functional Alterations of the Peritoneal Membrane. PERITONEAL DIALYSIS INTERNATIONAL. 2009; 29(2): 227-230 1,636
2009 Portoles, J; del Peso, G; Fernandez-Reyes, MJ; Bajo, MA; Lopez-Sanchez, P.Previous comorbidity and lack of patient free choice of technique predict early mortality in peritoneal dialysis. PERITONEAL DIALYSIS INTERNATIONAL. 2009; 29(2): 150-157 1,636
2009 Santamaria, B; Ucero, AC; Benito-Martin, A; Selgas, R; Ruiz-Ortega, M; Sanz, AB; Egido, J; Ortiz, A. Taming apoptosis in peritoneal dialysis. PERITONEAL DIALYSIS INTERNATIONAL. 2009; 29(Suppl 2): S45-8. 1,636
2009 Santamaria, B; Benito-Martin, A; Ucero, AC; Aroeira, LS; Reyero, A; Vicent, MJ; Orzaez, M; Celdran, A; Esteban, J; Selgas, R; Ruiz-Ortega, M; Cabrera, ML; Egido, J; Perez-Paya, E; Ortiz, A. A Nanoconjugate Apaf-1 Inhibitor Protects Mesothelial Cells from Cytokine-Induced Injury. PLOS ONE. 2009; 4(8): e6634. 4,351
2009 Froilan Torres,C.;Castro Carbajo,P.;Pajares Villarroya,R.;Plaza Santos,R.;Gomez Senent,S.;Martin Arranz,M. D.;Adan Merino,L.;Martin Arranz,E.;Mancenido Marcos,N.;Peces,R.;Benito Lopez,D.. Acute spontaneous tumor lysis syndrome in a patient with Crohn's disease taking immunosuppressants. REVISTA ESPAÑOLA DE ENFERMEDADES DIGESTIVAS. 2009; 101(4): 288-294 0,994
2009 Jimenez,C.;Lopez,M. O.;Gonzalez,E.;Selgas,R.. Ultrasonography in kidney transplantation: values and new developments. TRANSPLANTATION REVIEWS. 2009; 23(4): 209-213 N/A